1. Home
  2. TFX vs BLCO Comparison

TFX vs BLCO Comparison

Compare TFX & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

HOLD

Current Price

$132.16

Market Cap

5.8B

Sector

Health Care

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.96

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFX
BLCO
Founded
1943
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
5.4B
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
TFX
BLCO
Price
$132.16
$16.96
Analyst Decision
Buy
Buy
Analyst Count
8
11
Target Price
$138.75
$18.45
AVG Volume (30 Days)
389.7K
410.7K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
1.02%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,992,713,000.00
$5,101,000,000.00
Revenue This Year
$15.97
$8.65
Revenue Next Year
$5.15
$5.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.47
52 Week Low
$100.18
$13.20
52 Week High
$139.67
$18.92

Technical Indicators

Market Signals
Indicator
TFX
BLCO
Relative Strength Index (RSI) 54.93 50.49
Support Level $126.25 $15.56
Resistance Level $137.19 $16.73
Average True Range (ATR) 3.81 0.51
MACD -0.12 -0.03
Stochastic Oscillator 59.45 43.75

Price Performance

Historical Comparison
TFX
BLCO

About TFX Teleflex Incorporated

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: